FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

REAGENT WILL BE USED FOR THE IMMUNOTOXIN PROJECT IN DR PASTAN'S GROUP

Awarded to KERAFAST INC.

PIID 75N91021P00509US · USAspendingResearch & Science
$15.7K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$15,650sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateJun 3, 2021
Company legal name
KERAFAST INC.
UEI / CAGE
UPZ8NTQMGXB6 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Research & Science
NAICS
541715
PSC
6505
Performance period
Not reported — Not reported
Recipient address
27 DRYDOCK AVE FL 2, BOSTON, SUFFOLK, MA, 02210
Place of performance
BOSTON, SUFFOLK, MA, 02210
Source last modified
Nov 3, 2026

Description

REAGENT WILL BE USED FOR THE IMMUNOTOXIN PROJECT IN DR PASTAN'S GROUP

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    REAGENT WILL BE USED FOR THE IMMUNOTOXIN PROJECT IN DR PASTAN'S GROUP

    US · usaspendingSource ↗
  2. Value increased

    REAGENT WILL BE USED FOR THE IMMUNOTOXIN PROJECT IN DR PASTAN'S GROUP

    US · usaspending$15.7KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Jun 3, 20210Not reported$15,650.00Not reportedNot reportedREAGENT WILL BE USED FOR THE IMMUNOTOXIN PROJECT IN DR PASTAN'S GROUPUSAspending ↗